Evidence map›Paper›PMID 41246695›Full record

ReviewCureus2025

Biomaterial-Based Hemostasis: A Review of the Clinical and Functional Versatility of Oxidized Regenerated Cellulose.

Deepa Kanagal, Karthik Rao, Peter Gathoga, Kabir Moharana, Rajas Patil, Purva Jaiswal, Venkataraman Ap, Deepak Ts

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Effectiveness and Safety of Oxidized Regenerated Cellulose for Hemostasis in Joint Arthroplasty: A Systematic Review and Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Deepa KanagalObstetrics and Gynecology, Father Muller Medical College, Mangalore, IND.
Karthik RaoDepartment of Head, Neck Surgery and Oncology, Sri Shankara Cancer Hospital and Research Centre, Bengaluru, IND.
Peter GathogaDepartment of Obstetrics and Gynecology, Jacaranda Maternity Hospital, Nairobi, KEN.
Kabir MoharanaBiology, Stonehill International School, Bengaluru, IND.
Rajas PatilBiology, Stonehill International School, Bengaluru, IND.
Purva JaiswalClinical Affairs, Healthium Medtech Limited, Bengaluru, IND.
Venkataraman ApClinical Affairs, Healthium Medtech Limited, Bengaluru, IND.
Deepak TsClinical Affairs, Healthium Medtech Limited, Bengaluru, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidized Regenerated Cellulose (ORC) is a widely used polysaccharide-based hemostatic agent known for its biocompatibility, absorbability, antibacterial properties, and ease of application. It has been employed across a broad range of surgical specialties as an adjunctive tool for controlling mild to moderate bleeding, reducing postoperative adhesions, and minimizing infection risks. This scoping review aimed to evaluate the clinical efficacy, safety, functional versatility, and future potential of ORC across diverse surgical applications, with a focus on its comparative performance against other topical hemostatic agents. A systematic search of PubMed Central and clinicaltrials.gov database was conducted, including filters for only clinical trials, controlled trials, and randomized controlled trials involving human subjects. A total of 31 studies (28 from PubMed Central and three from clinicaltrials.gov) met the inclusion criteria, encompassing various surgical disciplines. Data were extracted on clinical indication, comparator agents, outcomes, and adverse events. ORC demonstrated consistent efficacy in controlling intraoperative bleeding, particularly in orthopedic, general, and gynecologic surgeries. It reduced total blood loss and postoperative drainage in specific contexts, though its hemostatic effect was less pronounced than fibrin-based sealants in high-pressure bleeding scenarios. It also contributed to adhesion prevention, particularly in pelvic and abdominal surgeries, and showed antibacterial activity against multidrug-resistant organisms. Adverse events were rare and typically unrelated to the material itself. In conclusion, ORC is a versatile, cost-effective hemostatic agent valued for its ease of use, rapid absorption, and intrinsic bactericidal properties. While newer, specialized agents may excel in specific high-risk scenarios, it remains a clinically indispensable option due to its balanced efficacy and safety profile, particularly in resource-limited settings. Further high-quality studies are warranted to solidify its evidence base across diverse surgical applications.

Indexed as

adhesion preventionoxidized regenerated cellulose (orc)postoperative bleeding controlsurgical hemostasissurgical site infection (ssi)topical hemostatic agent

Identifiers

PMID41246695
PMCPMC12619668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.